Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning

Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning

Abstract Background Stroke is the second leading cause of disease-related death and the third leading cause of disability worldwide. However, how to accurately warn of stroke onset remains extremely challenging. Recently, phenylacetyl glutamine (PAGln) has been implicated in the onset of stroke, but...

Full description

Bibliographic Details
Main Authors: Li Ma, Guoping Fu, Rongrong Liu, Feng Zhou, Shiye Dong, Yang Zhou, Jingwei Lou, Xinjun Wang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Neurology
Subjects:
Phenylacetyl glutamine
Stroke
LASSO regression
Risk factors
Machine learning
Online Access:https://doi.org/10.1186/s12883-023-03118-5

Internet

https://doi.org/10.1186/s12883-023-03118-5

Similar Items